1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome

Board Certified Critical Care Pharmacist Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Pathophysiology and Recognition of Critical Illness

1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness

2 Chapter 2: Medical Devices and Circulatory Support

2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care

3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management

3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation

4 Chapter 4: Vasoactive and Inotropic Therapy in Shock

4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock

5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)

5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness

6 Chapter 6: Cardiovascular Emergencies

6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias

7 Chapter 7: Pulmonary and Infectious Diseases in the ICU

7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU

8 Chapter 8: Neurocritical Care

8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury

9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies

9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy

10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition

10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral

11 Chapter 11: Quality, Safety, and Clinical Guidelines

11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions

12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine

12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management

13 Chapter 13: Treatment Planning and Care Coordination

13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education

1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome

Key Takeaways Explain This Topic AI

ICU-Acquired Weakness (ICUAW) encompasses Critical Illness Polyneuropathy (CIP) and Critical Illness Myopathy (CIM), presenting as diffuse, symmetric, flaccid weakness.

Risk factors for ICUAW include prolonged mechanical ventilation, sepsis, systemic inflammation, hyperglycemia, and the use of corticosteroids and neuromuscular blocking agents.

Post-Intensive Care Syndrome (PICS) describes long-term morbidities affecting critical illness survivors across three domains: physical, cognitive, and mental health.

Cognitive impairments in PICS often resemble mild traumatic brain injury or early Alzheimer's, while mental health issues frequently manifest as anxiety, depression, and PTSD.

The ABCDEF Bundle is a core preventative strategy for both ICUAW and PICS, emphasizing early mobility, optimal sedation practices, and family engagement.

Last updated: July 2026

ICU-Acquired Weakness and Post-Intensive Care Syndrome

The survival rates for critical illnesses have improved significantly over the past decades due to advances in intensive care medicine. However, this success has unmasked a substantial burden of long-term morbidity among survivors. Two of the most significant and overlapping phenomena affecting critically ill patients are ICU-Acquired Weakness (ICUAW) and Post-Intensive Care Syndrome (PICS). Recognizing the pathophysiology and risk factors for these conditions is essential for the modern critical care practitioner.

ICU-Acquired Weakness (ICUAW)

ICU-Acquired Weakness is defined as clinically detectable, symmetrical, and flaccid weakness that develops in critically ill patients, for which no plausible etiology exists other than the critical illness itself. It represents a spectrum of neuromuscular dysfunction that frequently complicates the course of severe sepsis, ARDS, and prolonged mechanical ventilation.

Pathophysiologic Mechanisms

The exact pathophysiology of ICUAW is complex and multifactorial, generally categorized into three primary manifestations:

Critical Illness Polyneuropathy (CIP): This is a primary axonal sensory-motor polyneuropathy. The microvascular dysfunction and systemic inflammation inherent to conditions like sepsis lead to endoneurial edema and a breakdown of the blood-nerve barrier. This exposes the peripheral nerves to neurotoxic factors, resulting in axonal degeneration. Electrophysiologically, CIP is characterized by reduced action potential amplitudes but relatively normal conduction velocities.

Critical Illness Myopathy (CIM): This is a primary disorder of the skeletal muscle fibers. It is characterized by muscle wasting, necrosis, and a profound loss of myosin (the thick myofilament). The severe catabolic state of critical illness, driven by pro-inflammatory cytokines, insulin resistance, and elevated cortisol, accelerates protein degradation and halts muscle synthesis.

Critical Illness Neuromyopathy (CINM): Many patients present with overlapping features of both CIP and CIM, which is referred to as critical illness neuromyopathy.

Risk Factors

The development of ICUAW is strongly associated with the severity and duration of critical illness. Key risk factors include:

Systemic Inflammatory Response Syndrome (SIRS) and Sepsis
Multiorgan failure
Prolonged mechanical ventilation and prolonged ICU stay

Medications: The use of systemic corticosteroids and neuromuscular blocking agents (NMBAs) are traditional risk factors, especially when used concurrently or in the presence of sepsis.

Hyperglycemia and poor glycemic control
Clinical Presentation and Diagnosis

Clinically, ICUAW presents as diffuse, symmetric, flaccid weakness, typically sparing the cranial nerves. Tendon reflexes may be diminished or absent. It is a major cause of failure to wean from mechanical ventilation due to diaphragmatic weakness.

Diagnosis is often clinical, utilizing the Medical Research Council (MRC) sum score. A score of less than 48 (out of 60) across 12 muscle groups indicates significant weakness. Nerve conduction studies and electromyography (EMG) can help differentiate between CIP and CIM but are technically challenging to perform in the ICU environment.

Post-Intensive Care Syndrome (PICS)

While ICUAW focuses on physical impairment, Post-Intensive Care Syndrome (PICS) encompasses a broader spectrum of new or worsening impairments that arise after a stay in the ICU and persist beyond the acute hospitalization. PICS describes the long-term consequences of critical illness across three distinct domains: physical, cognitive, and mental health.

The Three Domains of PICS

Physical Impairments: This domain is heavily driven by the long-term sequelae of ICUAW. Patients often experience persistent muscle weakness, reduced exercise capacity, fatigue, and difficulty with activities of daily living (ADLs). Joint contractures and chronic pain may also occur. Recovery can take months to years, and some patients never return to their baseline functional status.

Cognitive Impairments: A substantial portion of ICU survivors experience cognitive decline resembling mild traumatic brain injury or early Alzheimer's disease. Deficits typically involve executive functioning, memory, attention, and processing speed. The pathophysiology is linked to cerebral hypoperfusion during shock, neuroinflammation from sepsis, prolonged hypoxemia, and the neurotoxic effects of deep sedation and delirium.

Mental Health Impairments: Psychological morbidity is profound. Survivors frequently suffer from anxiety, depression, and Post-Traumatic Stress Disorder (PTSD). The trauma of the ICU experience, intrusive memories of hallucinations or procedures, and the frustration of physical limitations contribute heavily to these psychiatric outcomes.

PICS-Family

The impact of critical illness extends beyond the patient. PICS-Family (PICS-F) refers to the psychological distress—including anxiety, acute stress, PTSD, and depression—experienced by the family members of critically ill patients. The burden of caregiving, the uncertainty of the prognosis, and the trauma of witnessing a loved one's critical illness are major contributors.

Prevention and Management Strategies

There is no targeted pharmacological treatment for ICUAW or PICS; therefore, prevention and early mitigation are paramount. The cornerstone of prevention is adherence to the ABCDEF Bundle:

A ssess, Prevent, and Manage Pain
B oth Spontaneous Awakening Trials (SATs) and Spontaneous Breathing Trials (SBTs)
C hoice of Analgesia and Sedation (minimizing benzodiazepines)
D elirium: Assess, Prevent, and Manage
E arly Mobility and Exercise
F amily Engagement and Empowerment

Early mobilization, even while patients are intubated, has shown the greatest promise in reducing the incidence and severity of ICUAW and mitigating the physical aspects of PICS. Minimizing deep sedation and addressing delirium promptly are critical for protecting long-term cognitive and mental health.